![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Relative Bioavailability and Pharmacokinetics of Darunavir when boosted with the Pharmacoenhancer GS-9350 versus Ritonavir
|
|
|
Reported by Jules Levin
International Workshop on Clinical Pharmacology of HIV Therapy
April 7-9, 2010
Sorrento, Italy
Anita Mathias1, Hui C. Liu1, David Warren1, Vanitha Sekar2, and Brian P. Kearney11 Gilead Sciences, Inc., Foster City, CA 944042 Tibotec, Inc., Yardley, PA 19027
![](../images/042110/042110-11/image002.gif)
![](../images/042110/042110-11/image004.gif)
![](../images/042110/042110-11/image006.gif)
![](../images/042110/042110-11/image008.gif)
![](../images/042110/042110-11/image010.gif)
![](../images/042110/042110-11/image012.gif)
![](../images/042110/042110-11/image014.gif)
![](../images/042110/042110-11/image016.gif)
![](../images/042110/042110-11/image018.gif)
![](../images/042110/042110-11/image020.gif)
![](../images/042110/042110-11/image022.gif)
![](../images/042110/042110-11/image024.gif)
![](../images/042110/042110-11/image026.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|